IART - Integra LifeSciences Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IART is currently covered by 10 analysts with an average price target of $16.87. This is a potential upside of $3.73 (28.39%) from yesterday's end of day stock price of $13.14.

Integra LifeSciences Holdings's activity chart (see below) currently has 174 price targets and 150 ratings on display. The stock rating distribution of IART is 37.78% SELL, 37.78% HOLD and 24.44% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 76.42% with an average time for these price targets to be met of 167.56 days.

Highest price target for IART is $25, Lowest price target is $13, average price target is $22.5.

Most recent stock forecast was given by DAVID TURKALY from JMP on 09-May-2025. First documented stock forecast 15-Aug-2013.

Currently out of the existing stock ratings of IART, 17 are a SELL (37.78%), 17 are a HOLD (37.78%), 11 are a BUY (24.44%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$25

$11.86 (90.26%)

$35

2 months 26 days ago
(09-May-2025)

2/14 (14.29%)

$12.75 (104.08%)

435

Hold

$13

$-0.14 (-1.07%)

$25

2 months 29 days ago
(06-May-2025)

2/4 (50%)

$0.25 (1.96%)

4

Hold

$19

$5.86 (44.60%)

$21

3 months 24 days ago
(11-Apr-2025)

10/20 (50%)

$2.01 (11.83%)

28

Sell

$22

$8.86 (67.43%)

$16

8 months 30 days ago
(05-Nov-2024)

11/15 (73.33%)

$-2.91 (-11.68%)

90

Hold

$20

9 months 28 days ago
(07-Oct-2024)

8/8 (100%)

$-0.35 (-1.72%)

202

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IART (Integra LifeSciences Holdings) average time for price targets to be met?

On average it took 167.56 days on average for the stock forecasts to be realized with a an average price target met ratio 76.42

Which analyst has the current highest performing score on IART (Integra LifeSciences Holdings) with a proven track record?

DAVID TURKALY

Which analyst has the most public recommendations on IART (Integra LifeSciences Holdings)?

David Turkaly works at JMP and has 22 price targets and 14 ratings on IART

Which analyst is the currently most bullish on IART (Integra LifeSciences Holdings)?

Kaila Krum with highest potential upside - $42.07

Which analyst is the currently most reserved on IART (Integra LifeSciences Holdings)?

Larry Biegelsen with lowest potential downside - -$8

Integra LifeSciences Holdings in the News

JMP reiterates Market Outperform rating on Integra LifeSciences stock

Investing.com – JMP Securities has reiterated its Market Outperform rating and $25.00 price target on Integra LifeSciences (NASDAQ:IART) following the company’s second-quarter 2025 financial results. The medical device manufacturer, currently valued at $1.02 billion, has seen its shares decline nearly 50% over the past six months, though InvestingPro analysis suggests the stock is currently undervalued....

Integra (IART) Q2 Revenue Beats by 5%

Key Points Integra LifeSciences (NASDAQ:IART) delivered GAAP revenue of $415.6 million in Q2 2025, beating analyst estimates by $20.6 million (GAAP) or 5.2%. Adjusted earnings per share (EPS) reached $0.45, just above the consensus estimate, but down significantly from the prior year. Profitability and cash flow metrics remained under pressure, with a $511 million goodwill...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?